Esbriet, Ofev Found to Benefit IPF Patients in Clinical Practice
Esbriet, News
Two approved anti-fibrotics are proving to be safe and effective in treating idiopathic pulmonary fibrosis (IPF), a study with real-world data reports. The data showed Esbriet (pirfenidone) and Ofev (nintedanib) ... Read more